MapLight Therapeutics, Inc. - 8-K Filing

MapLight Therapeutics enters into $100 million at-the-market equity offering agreement with Leerink Partners LLC. (Items: 1.01 Entry Into A Material Definitive Agreement, 9.01 Financial Statement and Exhibits)

SEC EDGAR ·

Tickers: $MPLT

Read the full article at SEC EDGAR

More Regulatory news